Page last updated: 2024-10-21

3-nitropropionic acid and MELAS Syndrome

3-nitropropionic acid has been researched along with MELAS Syndrome in 1 studies

3-nitropropionic acid: succinate dehydrogenase inactivator; biosynthesized by FABACEAE plants from ASPARAGINE
3-nitropropanoic acid : A C-nitro compound that is propanoic acid in which one of the methyl hydrogens has been replaced by a nitro group.

MELAS Syndrome: A mitochondrial disorder characterized by focal or generalized seizures, episodes of transient or persistent neurologic dysfunction resembling strokes, and ragged-red fibers on muscle biopsy. Affected individuals tend to be normal at birth through early childhood, then experience growth failure, episodic vomiting, and recurrent cerebral insults resulting in visual loss and hemiparesis. The cortical lesions tend to occur in the parietal and occipital lobes and are not associated with vascular occlusion. VASCULAR HEADACHE is frequently associated and the disorder tends to be familial. (From Joynt, Clinical Neurology, 1992, Ch56, p117)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Moudy, AM1
Handran, SD1
Goldberg, MP1
Ruffin, N1
Karl, I1
Kranz-Eble, P1
DeVivo, DC1
Rothman, SM1

Other Studies

1 other study available for 3-nitropropionic acid and MELAS Syndrome

ArticleYear
Abnormal calcium homeostasis and mitochondrial polarization in a human encephalomyopathy.
    Proceedings of the National Academy of Sciences of the United States of America, 1995, Jan-31, Volume: 92, Issue:3

    Topics: Adenosine Triphosphate; Adolescent; Adult; Calcium; Calcium Channels; Cell Survival; Cells, Cultured

1995